These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24702741)

  • 1. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
    Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
    Nieder C; Pawinski A; Molls M
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors.
    Lewitzki V; Klement RJ; Hess S; Kosmala R; Nieder C; Flentje M
    Clin Transl Radiat Oncol; 2019 May; 16():15-20. PubMed ID: 30906886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
    Nieder C; Hess S; Lewitzki V
    Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indexes for brain metastases: which is the most powerful?
    Viani GA; da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e325-30. PubMed ID: 22633551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis.
    Gerdan L; Segedin B; Nagy V; Khoa MT; Trang NT; Schild SE; Rades D
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2108-10. PubMed ID: 23954201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels.
    Nieder C; Marienhagen K; Dalhaug A; Norum J
    ScientificWorldJournal; 2012; 2012():609323. PubMed ID: 22593701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
    Evers JN; Schild SE; Segedin B; Nagy V; Khoa MT; Trang NT; Rades D
    Anticancer Res; 2014 May; 34(5):2455-8. PubMed ID: 24778060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids.
    Nieder C; Norum J; Dalhaug A; Aandahl G; Engljähringer K
    Support Care Cancer; 2013 Oct; 21(10):2671-8. PubMed ID: 23686380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research.
    Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
    Tumour Biol; 2015 Aug; 36(8):6471-6. PubMed ID: 25801247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
    Partl R; Fastner G; Kaiser J; Kronhuber E; Cetin-Strohmer K; Steffal C; Böhmer-Breitfelder B; Mayer J; Avian A; Berghold A
    Support Care Cancer; 2016 Feb; 24(2):523-528. PubMed ID: 26105515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
    Sperduto CM; Watanabe Y; Mullan J; Hood T; Dyste G; Watts C; Bender GP; Sperduto P
    J Neurosurg; 2008 Dec; 109 Suppl():87-9. PubMed ID: 19123893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.